NRx Pharmaceuticals, Inc.NRXPNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank57
5Y CAGR-0.4%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
-0.4%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 28.58% |
| 2023 | 37.78% |
| 2022 | 53.43% |
| 2021 | -331.54% |
| 2020 | -2993.30% |
| 2019 | 29.14% |
| 2018 | 0.00% |
| 2017 | 0.00% |